STUDY ON NEURODEGENERATION USING TDP-43 TRANSGENIC RATS

TDP-43 转基因大鼠神经退行性研究

基本信息

  • 批准号:
    10198111
  • 负责人:
  • 金额:
    $ 31.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-06-19 至 2021-11-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Among known ALS genes, TDP-43 is of particular interest because its protein is hyper-phosphorylated and ubiquitinated in sporadic ALS. Compared with genetic mutation, post-translational modification is difficult to detect in patients and hard to reproduce in animal models. Therefore, a critical step toward understanding TDP-43 pathogenesis is revealing the pathways by which mutant TDP-43 causes neurodegeneration in ALS. TDP-43 binds to many RNAs and proteins, but how pathogenic mutation impacts TDP-43 function has not yet been determined, particularly in an appropriate animal model. Unexpectedly, overexpression of both WT and mutant TDP-43 in rodents causes indistinguishable phenotypes, indicating that excessive TDP-43 is neurotoxic. Because transgene expression is heavily influenced by position effect, the patterns and levels of transgene expression vary greatly from line to line. Whether mutant TDP-43 is more or less toxic than its WT form thus cannot be determined using existing transgenic models. The question regarding the impact of pathogenic mutation on TDP-43 function is further confounded by observations that TDP-43 depletion induces neurodegeneration in TDP-43 knock-out and knock-down mice. As TDP-43 binds to the 3'-untranslated region of its own mRNA and thereby regulates its own expression, the cDNA knock-in (KI) approach destroys TDP-43 self-regulatory machinery, rendering TDP-43 KI animals not very useful. Even 7 years after the discovery of TDP-43 mutation in ALS, whether mutant TDP-43 causes ALS through a gain or loss of function is still uncertain, and this unresolved issue is a roadblock to unraveling TDP-43 disease mechanisms. To resolve this critical issue, we created KI rats by introducing a single disease-linked point mutation into the rat genome. With the unprecedented rat models, we will determine how pathogenic mutation impacts TDP-43 function in a systematic manner.
 描述(由适用提供):在已知的ALS基因中,TDP-43特别感兴趣,因为其蛋白质被过度磷酸化并在零星的ALS中泛素化。与遗传突变相比,在动物模型中很难检测到翻译后修饰,并且很难繁殖。因此,了解TDP-43发病机理的关键步骤是揭示了突变体TDP-43在ALS中引起神经变性的途径。 TDP-43与许多RNA和蛋白质结合,但是尚未确定致病性突变如何影响TDP-43功能,尤其是在适当的动物模型中。出乎意料的是,啮齿动物中WT和突变体TDP-43的过表达导致无法区分的表型,这表明超级TDP-43是神经毒性的。由于转化表达受位置效应的严重影响,因此转化表达的模式和水平因线而异。因此,无法使用现有的转基因模型确定WT形式。关于致病突变对TDP-43功能的影响的问题进一步混淆,即TDP-43耗竭会诱导TDP-43敲除和敲除小鼠中的神经变性。随着TDP-43与其自己的mRNA的3'-非翻译区域结合,从而调节其自身的表达,cDNA敲入(KI)方法破坏了TDP-43自调节机制,使TDP-43 KI动物渲染不太有用。即使在ALS中发现TDP-43突变的7年后,突变体TDP-43是否通过功能的增长或丧失引起ALS仍然不确定,并且这个尚未解决的问题是揭示TDP-43疾病机制的障碍。为了解决这个关键问题,我们通过将单个疾病连接点突变引入大鼠基因组中创建了Ki大鼠。使用前所未有的大鼠模型,我们将确定致病性突变如何以系统的方式影响TDP-43功能。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pathogenic mutation in VPS35 impairs its protection against MPP(+) cytotoxicity.
XBP1 depletion precedes ubiquitin aggregation and Golgi fragmentation in TDP-43 transgenic rats.
  • DOI:
    10.1111/jnc.12014
  • 发表时间:
    2012-11
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    Tong J;Huang C;Bi F;Wu Q;Huang B;Zhou H
  • 通讯作者:
    Zhou H
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

hongxia zhou其他文献

hongxia zhou的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('hongxia zhou', 18)}}的其他基金

Study on Neurodegeneration using TDP-43 Transgenic Rats
TDP-43转基因大鼠神经变性研究
  • 批准号:
    9026917
  • 财政年份:
    2015
  • 资助金额:
    $ 31.48万
  • 项目类别:
Study on Neurodegeneration using TDP-43 Transgenic Rats
TDP-43转基因大鼠神经变性研究
  • 批准号:
    9195755
  • 财政年份:
    2015
  • 资助金额:
    $ 31.48万
  • 项目类别:
Study on Neurodegeneration Using TDP-43 Transgenic Rats
TDP-43转基因大鼠神经退行性疾病研究
  • 批准号:
    8392228
  • 财政年份:
    2011
  • 资助金额:
    $ 31.48万
  • 项目类别:
Study on Neurodegeneration Using TDP-43 Transgenic Rats
TDP-43转基因大鼠神经退行性疾病研究
  • 批准号:
    8191524
  • 财政年份:
    2011
  • 资助金额:
    $ 31.48万
  • 项目类别:
Study on Neurodegeneration Using TDP-43 Transgenic Rats
TDP-43转基因大鼠神经退行性疾病研究
  • 批准号:
    8575341
  • 财政年份:
    2011
  • 资助金额:
    $ 31.48万
  • 项目类别:

相似海外基金

Optimization of CRISPR genome editor and its delivery strategy for C9orf72 frontotemporal dementia
C9orf72额颞叶痴呆的CRISPR基因组编辑器优化及其递送策略
  • 批准号:
    10746565
  • 财政年份:
    2023
  • 资助金额:
    $ 31.48万
  • 项目类别:
Epigenetic mechanisms contributing to the pathogenesis of ALS/FTD with GGGGCC repeat expansion mutation at the C9orf72 locus
C9orf72 基因座 GGGGCC 重复扩增突变导致 ALS/FTD 发病的表观遗传机制
  • 批准号:
    10412699
  • 财政年份:
    2022
  • 资助金额:
    $ 31.48万
  • 项目类别:
Modulating miR-218 in human motor neurons using assembloids
使用组合体调节人类运动神经元中的 miR-218
  • 批准号:
    10525638
  • 财政年份:
    2022
  • 资助金额:
    $ 31.48万
  • 项目类别:
Modulating miR-218 in human motor neurons using assembloids
使用组合体调节人类运动神经元中的 miR-218
  • 批准号:
    10678680
  • 财政年份:
    2022
  • 资助金额:
    $ 31.48万
  • 项目类别:
Epigenetic Mechanisms Contributing to the Pathogenesis of ALS/FTD with GGGGCC Repeat Expansion Mutation at the C9orf72 Locus
C9orf72 基因座 GGGGCC 重复扩增突变导致 ALS/FTD 发病机制的表观遗传机制
  • 批准号:
    10792462
  • 财政年份:
    2022
  • 资助金额:
    $ 31.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了